Rainbow Seed Fund News

Eagle Genomics closes $3.5M investment, led by the Environmental Technologies Fund Investment to enable Eagle’s expansion into new markets to further develop sales & marketing and deepen development capability Microbiome focus addresses global environmental and health-related challenges LONDON – 31 January 2019 – Microbiome discovery platform company Eagle Genomics announces funding of $3.5M led by […]

read more

May 15th 2018 CellCentric has raised $26 million in private financing to fund clinical testing of its first-in-class oncology drug candidate CCS1477. The funds will be used to test the novel p300/CBP inhibitor in late stage, treatment-resistant prostate cancer (up to Phase IIb). Recent data shared at AACR also highlighted the potential of CCS1477 in […]

read more

Photo Glialign CEO John Sinden London, 2nd May 2018 The UCL Technology Fund (UCLTF), UK Innovation & Science Seed Fund (UKI2S), alongside support from Innovate UK, have invested in UCL spinout company Glialign Ltd, a company that is developing a novel cell therapy for peripheral nerve repair. Hundreds of thousands of people every year are affected […]

read more

1 2 3 9